Xiaolei Liang

Prof. Dr. Xiaolei Liang


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2023 in Journal of Ovarian Research
Verified
Journal Article
Open access
PDF file
QZQinying Zhu
Qinying Zhu
YLYi Li
Yi Li
JMJianhong Ma
Jianhong Ma
HMHao Ma
Hao Ma
XLXiaolei Liang
Xiaolei Liang
The ovarian reserve is defined as the quantity of oocytes stored in the ovary or the number of oocytes that can be recruited. Ovarian reserve can be affected by many factors, including hormones, metabolites, initial ovarian reserve, environmental problems, diseases, and medications, among others. With the trend of postponing of pregnancy in modern society, diminished ovarian reserve (DOR) has become one of the most common challenges in current clinical reproductive medicine. Attributed to its unclear mechanism and complex clinical features, it is difficult for physicians to administer targeted treatment. This review focuses on the factors associated with ovarian reserve and discusses the potential influences and pathogenic factors that may explain the possible mechanisms of DOR, which can be improved or built upon by subsequent researchers to verify, replicate, and establish further study findings, as well as for scientists to find new treatments.

1 July 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JZJingjing Zhou
Jingjing Zhou
LZLishi Zhang
Lishi Zhang
YHYuhang He
Yuhang He
KLKexin Liu
Kexin Liu
FZFangfang Zhang
Fangfang Zhang
KWKairong Wang
Kairong Wang

20 May 2020 in Scientific Reports
Verified
Journal Article
Open access
YYYongxiu Yang
Yongxiu Yang
MHMengwei Huang
Mengwei Huang
JQJinmei Qian
Jinmei Qian
DGDaqiang Gao
Daqiang Gao
XLXiaolei Liang
Xiaolei Liang
Magnetic hyperthermia is one of the most promising techniques for treating gynecological cancer, where magnetite (Fe3O4) is the most common nanomaterial used as a magnetic hyperthermia agent. Here, we demonstrate that optimal Fe3O4 nanorods (NRs) can act as a magnetic hyperthermia agent with higher specific absorption rate (SAR), which is mostly attributed to their enhanced surface anisotropy. As a result, Fe3O4 NRs could effectively hinder the growth of gynecological cancer cells in nude mice models, again demonstrating its good magnetic heating properties. These results provide a powerful basis for the development of an ideal magnetic hyperthermia agent with enhanced SAR, thereby effectively treating gynecological cancer in clinical practice.

1 January 2022 in Reproductive BioMedicine Online
Verified
Journal Article
Closed access
XYXiulan Yang
Xiulan Yang
ZZZhongying Zhao
Zhongying Zhao
QFQigang Fan
Qigang Fan
HLHongli Li
Hongli Li
LZLihui Zhao
Lihui Zhao
XLXiaolei Liang
Xiaolei Liang

28 August 2020 in PeerJ
Verified
Journal Article
Open access
PDF file
RHRuifen He
Ruifen He
ZZZhongying Zhao
Zhongying Zhao
YYYongxiu Yang
Yongxiu Yang
XLXiaolei Liang
Xiaolei Liang
Background: During fertility treatment, diminished ovarian reserve (DOR) is a challenge that can seriously affect a patient’s reproductive potential. However, the pathogenesis of DOR is still unclear and its treatment options are limited. This study aimed to explore DOR’s molecular mechanisms. Methods: We used R software to analyze the mRNA microarray dataset E-MTAB-391 downloaded from ArrayExpress, screen for differentially expressed genes (DEGs), and perform functional enrichment analyses. We also constructed the protein-protein interaction (PPI) and miRNA-mRNA networks. Ovarian granulosa cells (GCs) from women with DOR and the control group were collected to perform untargeted metabolomics analyses. Additionally, small molecule drugs were identified using the Connectivity Map database. Results: We ultimately identified 138 DEGs. Our gene ontology (GO) analysis indicated that DEGs were mainly enriched in cytokine and steroid biosynthetic processes. According to the Kyoto Encyclopedia of Genes and Genomes (KEGG), the DEGs were mainly enriched in the AGE (advanced glycation end-product)-RAGE (receptor for AGE) signaling pathway in diabetic complications and steroid biosynthesis. In the PPI network, we determined that JUN, EGR1, HMGCR, ATF3, and SQLE were hub genes that may be involved in steroid biosynthesis and inflammation. miRNAs also played a role in DOR development by regulating target genes. We validated the differences in steroid metabolism across GCs using liquid chromatography-tandem mass spectrometry (LC-MS/MS). We selected 31 small molecules with potentially positive or negative influences on DOR development. Conclusion: We found that steroidogenesis and inflammation played critical roles in DOR development, and our results provide promising insights for predicting and treating DOR.

15 November 2023 in Frontiers in Endocrinology
Verified
Journal Article
Open access
XQXue Qin
Xue Qin
JDJunhong Du
Junhong Du
RHRuifen He
Ruifen He
YLYi Li
Yi Li
QZQinying Zhu
Qinying Zhu
XLXiaolei Liang
Xiaolei Liang
Objective: To study the effect of type 2 diabetes mellitus(T2DM)on overall ovarian reserve and pregnancy outcomes during assisted reproductive technology (ART) among childbearing infertile women.Design: Retrospective cohort study.Setting: The Reproductive Medicine Special Hospital, The First Hospital of Lanzhou University, between January 2019 and December 2022.Patient(s): A total of 265 infertile female patients aged 20–45 years who underwent in vitro fertilization-embryo transfer (IVF-ET), intracytoplasmic sperm injection-embryo transfer (ICSI-ET), or rescue intracytoplasmic sperm injection-embryo transfer (RICSI-ET) in the first fresh cycle.Intervention(s): None.Main Outcome Measure(s): Serum Anti-Müllerian Hormone (AMH) levels, clinical pregnancy rate (CPR), live birth rate (LBR), and abortion rate (AR) in the T2DM group and non-T2DM group.Result(s): Patients with T2DM showed statistically decreased levels of AMH compared to the non-T2DM group. During ovarian stimulation, those with T2DM required significantly higher total and initial doses of gonadotropin (GN), although they had fewer retrieved oocytes and worse pregnancy outcomes than the non-T2DM group. Multivariate logistic regression analysis adjusting for confounding factors showed that T2DM alone was an independent risk factor for CPR and LBR (adjusted odds ratio [a OR], 0.458, adjusted 95% confidence interval [CI], 0.235-0.891, P = 0.022; a OR, 0.227, 95% CI, 0.101-0.513, P<0.001; respectively), and the abortion rate in the T2DM group was 3.316 times higher than the non-T2DM group(a OR, 3.316, 95%CI, 1.248-8.811, P = 0.016);Conclusion: Infertile patients with T2DM have decreased ovarian reserve, and T2DM has a deleterious impact on clinical pregnancy outcomes during the ART process compared with non-T2DM infertile women.Capsule: Infertile women with T2DM have decreased ovarian reserve and pregnancy outcomes during the assisted reproductive technology process compared with non-T2DM infertile women.